-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the primary prevention , the plasma ω3 polyunsaturated fatty acids (ω3-PUFAs) and medsci.
Prevention of medsci.
Recently, a research article was published in JAHA, an authoritative journal in the field of cardiovascular diseases, in this case cohort of 203 patients with cardiovascular deaths, 325 patients with myocardial infarction , 271 patients with ventricular arrhythmia, and 161 patients with atrial fibrillation In the study, the researchers assessed the subjects' basic plasma ω3-PUFA levels (α-linolenic acid, eicosapentaenoic acid, dodecosapentaenoic acid, and docosahexaenoic acid) through gas chromatography.
Myocardial infarction
After the inverse probability weighted multivariate adjustment including all traditional risk factors, the proportion of long-chain ω3-PUFA (eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid) is relatively high , The probability of cardiovascular death was reduced by 18% (the odds ratio [OR] of [adj] adjusted for every 1 SD was 0.
There is a correlation between α-linolenic acid and subsequent cardiovascular disease probability (adj OR 0.
It can be seen that in patients with acute coronary syndrome , long-chain ω3-PUFA in plasma is negatively correlated with the reduced probability of sudden cardiac death, but has nothing to do with traditional risk factors and blood lipids .
In patients with acute coronary syndrome , long-chain ω3-PUFA in plasma is negatively correlated with the reduced probability of sudden cardiac death, but has nothing to do with traditional risk factors and blood lipids.
Original source:
Thomas A.
Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36 Leave a message here